Cancer• Full Transcript Included
The Revolution in Early Cancer Detection: Liquid Biopsy & Biomarker Screening
Interview Overview & Clinical Context
Dr. Rohini Ramanathan discusses breakthroughs in circulating tumor DNA (ctDNA) technology, genomic risk stratification, and why early detection converts terminal prognoses into treatable scenarios.
Key Discussion Points & Takeaways
- Liquid biopsies can detect cancer DNA fragments in peripheral blood months before radiological evidence appears.
- Targeted immunotherapies are replacing traditional chemotherapeutic toxicities in triple-negative cases.
- Routine screening protocols (Mammography, Pap smears, Colonoscopies) remain the bedrock of early survival.
Full Recorded Transcript
Full transcript: The shift from late-stage systemic therapy to molecular interception before clinical metastasis is the biggest victory in oncology over the past decade...
[End of audio transcript • Recorded under HealthGhuru Editorial Standards]
Notice: Opinions and clinical insights expressed in this interview are those of the featured medical specialist and reflect current peer-reviewed consensus. Always consult your personal physician before making therapeutic modifications.